Joellen M. Schildkraut
Department of Community and Family Medicine
Duke University Medical Center
Box 2949
Durham
USA
Name/email consistency: high
- Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. Schildkraut, J.M., Iversen, E.S., Wilson, M.A., Clyde, M.A., Moorman, P.G., Palmieri, R.T., Whitaker, R., Bentley, R.C., Marks, J.R., Berchuck, A. PLoS. ONE (2010)
- Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Schildkraut, J.M., Goode, E.L., Clyde, M.A., Iversen, E.S., Moorman, P.G., Berchuck, A., Marks, J.R., Lissowska, J., Brinton, L., Peplonska, B., Cunningham, J.M., Vierkant, R.A., Rider, D.N., Chenevix-Trench, G., Webb, P.M., Beesley, J., Chen, X., Phelan, C., Sutphen, R., Sellers, T.A., Pearce, L., Wu, A.H., Van Den Berg, D., Conti, D., Elund, C.K., Anderson, R., Goodman, M.T., Lurie, G., Carney, M.E., Thompson, P.J., Gayther, S.A., Ramus, S.J., Jacobs, I., Krüger Kjaer, S., Hogdall, E., Blaakaer, J., Hogdall, C., Easton, D.F., Song, H., Pharoah, P.D., Whittemore, A.S., McGuire, V., Quaye, L., Anton-Culver, H., Ziogas, A., Terry, K.L., Cramer, D.W., Hankinson, S.E., Tworoger, S.S., Calingaert, B., Chanock, S., Sherman, M., Garcia-Closas, M. Cancer Res. (2009)
- Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. Schildkraut, J.M., Moorman, P.G., Bland, A.E., Halabi, S., Calingaert, B., Whitaker, R., Lee, P.S., Elkins-Williams, T., Bentley, R.C., Marks, J.R., Berchuck, A. Cancer Epidemiol. Biomarkers Prev. (2008)
- Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Schildkraut, J.M., Murphy, S.K., Palmieri, R.T., Iversen, E., Moorman, P.G., Huang, Z., Halabi, S., Calingaert, B., Gusberg, A., Marks, J.R., Berchuck, A. Cancer Epidemiol. Biomarkers Prev. (2007)
- Analgesic drug use and risk of ovarian cancer. Schildkraut, J.M., Moorman, P.G., Halabi, S., Calingaert, B., Marks, J.R., Berchuck, A. Epidemiology (2006)
- IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men. Schildkraut, J.M., Demark-Wahnefried, W., Wenham, R.M., Grubber, J., Jeffreys, A.S., Grambow, S.C., Marks, J.R., Moorman, P.G., Hoyo, C., Ali, S., Walther, P.J. Cancer Epidemiol. Biomarkers Prev. (2005)
- Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. Schildkraut, J.M., Calingaert, B., Marchbanks, P.A., Moorman, P.G., Rodriguez, G.C. J. Natl. Cancer Inst. (2002)
- Age at natural menopause and the risk of epithelial ovarian cancer. Schildkraut, J.M., Cooper, G.S., Halabi, S., Calingaert, B., Hartge, P., Whittemore, A.S. Obstet. Gynecol (2001)
- Prognostic factors in early-onset epithelial ovarian cancer: a population-based study. Schildkraut, J.M., Halabi, S., Bastos, E., Marchbanks, P.A., McDonald, J.A., Berchuck, A. Obstet. Gynecol (2000)
- Environmental contaminants and body fat distribution. Schildkraut, J.M., Demark-Wahnefried, W., DeVoto, E., Hughes, C., Laseter, J.L., Newman, B. Cancer Epidemiol. Biomarkers Prev. (1999)